Your browser doesn't support javascript.
loading
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.
Kim, Mi-Jeong; Kim, Ji Young; Shin, Ji Hye; Kang, Yeeun; Lee, Ji Su; Son, Juhee; Jeong, Soo-Kyung; Kim, Daesik; Kim, Duk-Hwan; Chun, Eunyoung; Lee, Ki-Young.
Afiliação
  • Kim MJ; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Kim JY; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Shin JH; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Kang Y; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Lee JS; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Son J; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Jeong SK; R&D Center, CHA Vaccine Institute, Seongnam-si, 13493, Republic of Korea.
  • Kim D; Department of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Kim DH; Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea.
  • Chun E; R&D Center, CHA Vaccine Institute, Seongnam-si, 13493, Republic of Korea. echun@chamc.co.kr.
  • Lee KY; Department of Immunology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 16419, Republic of Korea. thylee@skku.edu.
Cell Biosci ; 13(1): 102, 2023 Jun 07.
Article em En | MEDLINE | ID: mdl-37287005

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article